Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey

Show simple item record

dc.date.accessioned 2022-06-09T13:25:07Z
dc.date.available 2022-06-09T13:25:07Z
dc.date.issued 2022-06-09 en
dc.identifier.uri http://hdl.handle.net/20.500.11910/19445
dc.description.abstract Tuberculosis remains an important clinical and public health issue in South Africa, which has one of the highest tuberculosis burdens in the world. We aimed to estimate the burden of bacteriologically confirmed pulmonary tuberculosis among people aged 15 years or older in South Africa. This multistage, cluster-based, cross-sectional survey included eligible residents in 110 clusters nationally (cluster size of 500 people; selected by probability proportional-to-population size sampling). Participants completed face-to-face symptom questionnaires (for cough, weight loss, fever, and night sweats) and manually read digital chest X-ray screening. Screening was recorded as positive if participants had at least one symptom or an abnormal chest X-ray suggestive of tuberculosis, or a combination thereof. Sputum samples from participants who were screen-positive were tested by the Xpert MTB/RIF Ultra assay (first sample) and Mycobacteria Growth Indicator Tube culture (second sample), with optional HIV testing. Participants with a positive Mycobacterium tuberculosis complex culture were considered positive for bacteriologically confirmed pulmonary tuberculosis; when culture was not positive, participants with a positive Xpert MTB/RIF Ultra result with an abnormal chest X-ray suggestive of active tuberculosis and without current or previous tuberculosis were considered positive for bacteriologically confirmed pulmonary tuberculosis. Between Aug 15, 2017, and July 28, 2019, 68771 people were enumerated from 110 clusters, with 53250 eligible to participate in the survey, of whom 35191 participated. 9066 of 35191 participants were screen positive and 234 were identified as having bacteriologically confirmed pulmonary tuberculosis. Overall, the estimated prevalence of bacteriologically confirmed pulmonary tuberculosis was 852 cases per 100000 population; the prevalence was highest in people aged 35-44 years per 100000 population) and those aged 65 years or older per 100000 population). The estimated prevalence was approximately 1-6 times higher in men than in women per 100000 population vs 675 cases per 100000 population). 135 of 234 participants with tuberculosis screened positive by chest X-ray only, 16 by symptoms only, and 82 by both. 55 of 191 participants with tuberculosis with known HIV status were HIV-positive Pulmonary tuberculosis prevalence in this survey was high, especially in men. Despite the ongoing burden of HIV, many participants with tuberculosis in this survey did not have HIV. As more than half of the participants with tuberculosis had an abnormal chest X-ray without symptoms, prioritising chest X-ray screening could substantially increase case finding. en
dc.format.medium Print en
dc.subject TUBERCULOSIS en
dc.subject HEALTH CARE en
dc.subject RISK BEHAVIOUR en
dc.title Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey en
dc.type Journal Article en
dc.description.version Y en
dc.ProjectNumber N/A en
dc.Volume May en
dc.BudgetYear 2022/23 en
dc.ResearchGroup Inclusive Economic Development en
dc.ResearchGroup Human and Social Capabilities en
dc.SourceTitle The Lancet Infectious Diseases en
dc.ArchiveNumber 9812372 en
dc.PageNumber Online en
dc.outputnumber 13879 en
dc.bibliographictitle Moyo, S., Ismail, F., van der Walt, M., Ismail, N., Mkhondo, N., Dlamini, S., Mthiyane, T., Chikovore, J., Oladimeji, O., Mametja, D., Maribe , P., Seocharan, I., Ximiya, P., Law, I., Tadolini, M., Zuma, K., Manda, S., Sismanidis, C., Pillay, Y. & Mvusi, L. (2022) Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey. The Lancet Infectious Diseases. May:Online. en
dc.publicationyear 2022 en
dc.contributor.author1 Moyo, S. en
dc.contributor.author2 Ismail, F. en
dc.contributor.author3 van der Walt, M. en
dc.contributor.author4 Ismail, N. en
dc.contributor.author5 Mkhondo, N. en
dc.contributor.author6 Dlamini, S. en
dc.contributor.author7 Mthiyane, T. en
dc.contributor.author8 Chikovore, J. en
dc.contributor.author9 Oladimeji, O. en
dc.contributor.author10 Mametja, D. en
dc.contributor.author11 Maribe , P. en
dc.contributor.author12 Seocharan, I. en
dc.contributor.author13 Ximiya, P. en
dc.contributor.author14 Law, I. en
dc.contributor.author15 Tadolini, M. en
dc.contributor.author16 Zuma, K. en
dc.contributor.author17 Manda, S. en
dc.contributor.author18 Sismanidis, C. en
dc.contributor.author19 Pillay, Y. en
dc.contributor.author20 Mvusi, L. en


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record